ATE298239T1 - Immunomodulierende zusammensetzungen enthaltend harnstoff derivate zur behandlung von entzündungskrankheiten - Google Patents
Immunomodulierende zusammensetzungen enthaltend harnstoff derivate zur behandlung von entzündungskrankheitenInfo
- Publication number
- ATE298239T1 ATE298239T1 AT00920167T AT00920167T ATE298239T1 AT E298239 T1 ATE298239 T1 AT E298239T1 AT 00920167 T AT00920167 T AT 00920167T AT 00920167 T AT00920167 T AT 00920167T AT E298239 T1 ATE298239 T1 AT E298239T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- compositions containing
- inflammatory diseases
- urea derivatives
- containing urea
- Prior art date
Links
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical class NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title 1
- 230000002519 immonomodulatory effect Effects 0.000 title 1
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12817799P | 1999-04-06 | 1999-04-06 | |
| US18842200P | 2000-03-10 | 2000-03-10 | |
| PCT/US2000/009087 WO2000059490A2 (en) | 1999-04-06 | 2000-04-06 | Immunomodulating composition for use especially in the treatment of inflammations, infections and surgical adhesions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE298239T1 true ATE298239T1 (de) | 2005-07-15 |
Family
ID=26826354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00920167T ATE298239T1 (de) | 1999-04-06 | 2000-04-06 | Immunomodulierende zusammensetzungen enthaltend harnstoff derivate zur behandlung von entzündungskrankheiten |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1171136B1 (de) |
| JP (1) | JP2002541099A (de) |
| AT (1) | ATE298239T1 (de) |
| DE (1) | DE60020951T2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8658148B2 (en) | 2007-06-22 | 2014-02-25 | Genzyme Corporation | Chemically modified dendrimers |
| CN112584878A (zh) * | 2018-08-30 | 2021-03-30 | 樱花精机株式会社 | 腱和腱鞘的再生、修复材料及修复材料的应用 |
| WO2021217041A1 (en) * | 2020-04-24 | 2021-10-28 | Immvention Therapeutix | N-substituted alpha-amino and alpha-hydroxy carboxamide derivatives |
-
2000
- 2000-04-06 AT AT00920167T patent/ATE298239T1/de not_active IP Right Cessation
- 2000-04-06 JP JP2000609054A patent/JP2002541099A/ja active Pending
- 2000-04-06 EP EP00920167A patent/EP1171136B1/de not_active Expired - Lifetime
- 2000-04-06 DE DE60020951T patent/DE60020951T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1171136A2 (de) | 2002-01-16 |
| JP2002541099A (ja) | 2002-12-03 |
| EP1171136B1 (de) | 2005-06-22 |
| DE60020951T2 (de) | 2006-05-24 |
| DE60020951D1 (de) | 2005-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| DE60108754D1 (de) | Substituierte bizyklische derivate für die behandlung von unnormalem zellwachstum | |
| ATE308997T1 (de) | Mittel zur behandlung von erkrankungen der speiseröhre | |
| DE60028358D1 (de) | Hmg1 antagonisten zur behandlung von entzündungen | |
| DE60031710D1 (de) | Fettsäurederivat zur behandlung von externen sekretionsstörungen | |
| DE69734513D1 (de) | Phenylamino-substituierte triicyclische derivate zur behandlung hyperproliferativer krankheiten | |
| DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
| ATE455106T1 (de) | Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen | |
| EP1017402A4 (de) | Behandlung des übersäuerten darmsyndroms | |
| ATE275145T1 (de) | Chinazolinderivate zur behandlung von tumoren | |
| NO20012995L (no) | Forbindelser nyttige for behandling av inflammatoriske sykdommer | |
| ATE350364T1 (de) | Adamantanderivate zur behandlung von entzündlichen, immunologischen und kardiovaskulären erkrankungen | |
| ATE269303T1 (de) | Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen | |
| DE60023872D1 (de) | Verfahren zur erhöhung der biologischen effektivität von zusammensetzungen zur pflanzenbehandlung | |
| DE10082139T1 (de) | Zusammensetzung zur Behandlung von Reibungspaaren | |
| DE60030554D1 (de) | Verwendungen von et743 zur behandlung von krebs | |
| EE200100397A (et) | Kompositsioonid inflammatoorse reaktsiooni käitluseks | |
| EP1117431A4 (de) | Behandlung von acidose | |
| DE69913380D1 (de) | Zusammensetzung zur behandlung von periodontalen erkrankungen | |
| DE60021252D1 (de) | Antikonvulsiva zur behandlung von autismus | |
| NO20012541D0 (no) | Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner | |
| ATE430577T1 (de) | Ppar delta-inhibitoren zur behandlung kardiovasculärer erkrankungen | |
| DE60120990D1 (de) | Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen | |
| DE60020951D1 (de) | Immunomodulierende zusammensetzungen enthaltend harnstoff derivate zur behandlung von entzündungskrankheiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |